[
  {
    "ts": null,
    "headline": "2 Warren Buffett Stocks To Buy Hand Over Fist and 1 To Avoid",
    "summary": "Most of them are always worth buying. Every now and then, even the Oracle of Omaha misses something important.",
    "url": "https://finnhub.io/api/news?id=5c2dc7453c352577a2114145873a57c567664d91397c1ec0de555c75bf1fa4a2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759013940,
      "headline": "2 Warren Buffett Stocks To Buy Hand Over Fist and 1 To Avoid",
      "id": 136904062,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "Most of them are always worth buying. Every now and then, even the Oracle of Omaha misses something important.",
      "url": "https://finnhub.io/api/news?id=5c2dc7453c352577a2114145873a57c567664d91397c1ec0de555c75bf1fa4a2"
    }
  },
  {
    "ts": null,
    "headline": "What Catalysts Are Shaping the Evolving Narrative for UnitedHealth?",
    "summary": "UnitedHealth Group has seen a modest uptick in its consensus analyst price target, rising from $333.42 to $342.58. This change comes as investors react to improved Medicare Advantage Star ratings, which has bolstered confidence in the company’s long-term prospects. Stay tuned to discover how ongoing updates and analyst perspectives could shape the narrative for UnitedHealth Group in the future. What Wall Street Has Been Saying Analyst sentiment toward UnitedHealth Group has become more...",
    "url": "https://finnhub.io/api/news?id=3f17b14edb2b2be4feebb7a81c64a93ad6b4ff0f1b1f8fb550cf58db4b8fd234",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758982853,
      "headline": "What Catalysts Are Shaping the Evolving Narrative for UnitedHealth?",
      "id": 136904063,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "UnitedHealth Group has seen a modest uptick in its consensus analyst price target, rising from $333.42 to $342.58. This change comes as investors react to improved Medicare Advantage Star ratings, which has bolstered confidence in the company’s long-term prospects. Stay tuned to discover how ongoing updates and analyst perspectives could shape the narrative for UnitedHealth Group in the future. What Wall Street Has Been Saying Analyst sentiment toward UnitedHealth Group has become more...",
      "url": "https://finnhub.io/api/news?id=3f17b14edb2b2be4feebb7a81c64a93ad6b4ff0f1b1f8fb550cf58db4b8fd234"
    }
  }
]